Aceso Life Science Group Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was HKD 228 million compared to HKD 312 million a year ago. Net loss was HKD 462 million compared to HKD 264 million a year ago.

Basic loss per share from continuing operations was HKD 0.0635 compared to HKD 0.0361 a year ago. Diluted loss per share from continuing operations was HKD 0.0635 compared to HKD 0.0361 a year ago.